Novo Holdings A/S’s CureVac CVAC Stock Holding History

Novo Holdings A/S’s Portfolio CVAC Stock Details CVAC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-201,642	Closed	-$9.39M	–	47
2020 Q3	$9.39M	Buy	+201,642	New	+$11.2M	0.47%	31

Other funds holding CVAC

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Gates Foundation Seattle, Washington $43.5M AUM 14.19% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return

Novo Holdings A/S's CVAC Position: Q4 2020 in Review

Novo Holdings A/S sold out of CureVac (CVAC) in Q4 2020, closing a stake of 201,642 shares — an estimated $9.39M sold.

Novo Holdings A/S first reported a position in CVAC in Q3 2020 and held it in 1 quarter. The position peaked at $9.39M in Q3 2020. 61 funds tracked by Wall St. Rank hold CVAC as of Q4 2020.

Novo Holdings A/S reported no remaining CureVac position as of Q4 2020 after selling out during the quarter.
Novo Holdings A/S sold 201,642 CureVac shares in Q4 2020, an estimated $9.39M.
Novo Holdings A/S first reported a position in CureVac in Q3 2020 and held it in 1 quarter.
Novo Holdings A/S's CureVac position peaked at $9.39M in Q3 2020.
61 funds tracked by Wall St. Rank held CureVac as of Q4 2020.

Based on Novo Holdings A/S's 13F filing for Q4 2020, filed 16 Feb 2021.